Arcturus Therapeutics
ARCT
$26.63
Share price
0.30%
Change (1 day)
1.95%
Change (1 year)
Arcturus Therapeutics (ARCT) Fails to deliver data
Key failure to deliver metrics for Arcturus Therapeutics :
- Last SEC data release: 2024-03-28
- Last 15 days FTD volume: $0.16 M
- Last 3 months FTD volume: $0.38 M
- Last year FTD volume: $2.81 M
Failures to deliver for Arcturus Therapeutics (ARCT) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Arcturus Therapeutics (ARCT) - since 2019
Volume in USD (price x number of shares), data since 2019Arcturus Therapeutics (ARCT) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $0.38 M | -89.29% |
| 2023 | $3.58 M | -91.03% |
| 2022 | $39.97 M | -83.32% |
| 2021 | $0.23 B | 150.65% |
| 2020 | $95.61 M | 7113.8% |
| 2019 | $1.32 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | $0.03 M | $0.2 M | Bahamas |
 NRC Health
NRC | $0.25 M | $1.53 M | 🇺🇸 USA |